The extensive SURPASS clinical trials, encompassing eight completed studies, have evaluated tirzepatide as both monotherapy and in combination with other treatments (4)
What Are the Different Kinds of GLP-1 Agonist Treatments
Fatigue From Disease and Aging Fatigue is common in cancer patients after treatments from chemotherapy, radiation therapy, and poor nutrition
Bitters stimulate bitter receptors, which release enzymes throughout the digestive tract
Some data suggest neuroprotective properties, and there are ongoing randomised trials among patients with neurological and psychiatric disorders (NCT04466345)
GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors observed in animal studies, and while the relevance to humans remains uncertain, patients with personal or family history of medullary thyroid carcinoma should not use these medications